Text Messaging Reminders for Influenza Vaccine in Primary Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required.

Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician

NCT06123936

Influenza Viral Infections

RECRUITING NA

Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children

NCT01662583

Influenza

COMPLETED NA

Pilot Text Message for Influenza Vaccination

NCT01761734

Influenza

COMPLETED NA

Influenza Reminder Text-Messaging

NCT06587984

Influenza

COMPLETED NA

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

NCT02284594

Influenza

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care

Practices in the standard care arm will proceed with their seasonal influenza campaign as planned.

Group Type OTHER

Standard care

Intervention Type OTHER

Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.

Text messaging intervention

Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.

Group Type EXPERIMENTAL

Text message influenza vaccination reminder

Intervention Type OTHER

Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Text message influenza vaccination reminder

Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.

Intervention Type OTHER

Standard care

Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* practices must use text messaging software to communicate with patients;
* practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season.
* practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression